1
The relative stereochemistry of 1 was established on the basis of H NMR data and ROESY experiments. The strong
cross peaks of H-7 to H -9 and H-9ꢀꢂ, H -9 to H-8ꢀ and H-7, and H-8ꢀ to H-9ꢀꢂ and H -9 indicated that H-7, H -9, and H-8ꢀ had
2
2
2
2
ꢂ orientations, similar to those of lanicepsides A and B [6], tinosposide B [11], and tanegosides A, B, and C [12]. The relative
configuration of H-7ꢀ was determined as having a ꢅ orientation by comparison of the chemical shift and coupling constant of
H-7ꢀ with those of lanicepsides Aand B [6], tinosposide B [11], and tanegool [13], further supported by the ROESY correlation
between H-7ꢀ and H-9ꢅ. Thus, the structure of compound 1 was identified as shown and named 9-acetyl lanicepside B.
Compounds 2–6 were identified as lanicepside A (2) [6], plantainoside D (3) [7], plantamajoside (4) [8], (–)-woonenoside
XI (5) [9], and syringin (6) [10] by comparing their physical and spectral data with the data reported in the literature.
All compounds isolated form this herb were evaluated against three tumor cell lines, A549, HL-60, and P388 (Table 2).
9
7
3
-Acetyl lanicepside B (1) showed weak in vitro cytotoxic activities against A549 and P388 with IC50 values of 64.7 ꢁM and
2.5 ꢁM, respectively. Syringin (6) showed moderate in vitro cytotoxic activities against A549 and HL-60 with IC values of
2.5 ꢁM and 41.8 ꢁM, respectively.
50
EXPERIMENTAL
General Experimental Procedures. Optical rotations were measured on a Perkin–Elmer polarimeter 341. IR spectra
–
1
were determined on a Nicolet Magna FT-IR 750 spectrometer (ꢇ , cm ). The NMR spectra were recorded on Bruker DRX-400
max
13
1
NMR and Varian UNITYINOVA 600 spectrometers for H and C NMR. The chemical shifts are given on the ꢄ (ppm) scale
with tetramethylsilane as an internal standard, and coupling constants (J) are in Hz. The ESI-MS and HR-ESI-MS data were
recorded on a Q-TOF Micro LC-MS-MS mass spectrometer. Preparative and semipreparative HPLC system: two PrepStar
SD-1 solvent delivery modules, a ProStar UV-Vis 320 detector and a ProStar 701 fraction collector (Varian, Walnut Creek,
CA, USA); a LinChrospher 100 RP-18 (Merck, Darmstadt, Germany) column (220 ꢈ 25 mm i.d.; particle size 5 ꢁm) for
TM
preparative isolation; a XTerra C column (3.5 ꢁm; 250 ꢈ 10 mm, waters) for semi-preparative isolation. Commercial silica
18
gel (Qing Dao Hai Yang Chemical Group Co., 200–300 and 400–600 mesh) was used for column chromatography. Precoated
Si gel plates (Yan Tai Zi Fu Chemical Group Co., G60 F-254) were used for analytical TLC.
Plant Material. The whole plant of B. himalaica were collected in Dali County, Yunnan Province, P. R. China in
September, 2006 and identified by Prof. Shukun Chen of Kunming Institute of Botany, ChineseAcademy of Sciences, Kunming,
P. R. China. A voucher specimen (20060913B) is deposited in the Herbarium of South-Central University for Nationalities,
Wuhan, P. R. China.
Extraction and Isolation. The air-dried whole plant of B. himalaica (200 g) were percolated with 95% aq. EtOH
(
1 L ꢈ 3) at room temperature. The EtOH extract was filtered and concentrated under reduced pressure. Then the concentrated
extract was suspended in H O and partitioned with n-BuOH (1 L ꢈ 3). The n-BuOH fraction (8 g) was subjected to CC over
2
polyamide resin (300 g) and eluted with 0%, 20, 40, 60, and 80% aq. EtOH in a step manner. The fraction eluted with 20% aq.
EtOH was applied to a silica gel column (CHCl –MeOH–H O 9:3:0.2) to afford subfractions 1.1–1.6. Subfraction 1.2 was
3
2
submitted to prep. TLC (CHCl –MeOH–H O 9:3:0.2) to yield 1 (2 mg) and 2 (5 mg). Subfraction 1.3 was submitted to
3
2
semipreparative HPLC (H O–MeOH 95% : 5%ꢉ75%:25%, 35 min) to give 3 (7 mg, 9.6 min) and 4 (8 mg, 10.9 min). Subfraction
2
1
.4 was subjected to CC over silica gel and then preparative TLC (CHCl –MeOH–H O 8:3:0.2) to give 5 (11 mg) and 6 (13 mg).
3 2
2
5
9
-Acetyl Lanicepside B (1). Light yellow powder; [ꢂ] –19.0ꢃ (c 0.1, MeOH). UV (MeOH, ꢊmax, nm): 220, 276.
D
–1
1
13
IR (ꢇmax, film, cm ): 3366, 2926, 1745, 1605, 1517, 1465, 1264, 1227, 1161, 1068, 1025, 817. H and C NMR, see Table 1;
HR-ESI-MS m/z 603.2059 [M + Na] (C H O Na, calcd 603.2054).
+
28
36 13
Cytotoxicity Assay. Cell lines A549 (human lung carcinoma), HL-60 (human promyelocytic leukemia), and P388
(
murine leukemia) were purchased from the American Type Culture Collection (ATCC; Rockville, MD, USA). The cytotoxic
assay was performed as previously described [14]. Briefly, three cell lines suspended in RPMI 1640 containing 10% FBS were
4
seeded at 1 ꢈ 10 cells (100 ꢁL) per well in a flat 96-well plate and incubated in a humidified atmosphere of 5% CO in air at
2
3
7ꢃC. After 24 h, the medium containing different concentrations of compounds 1–6 was added, and 0.1% DMSO was used as
solvent control. After that, the cells were fixed with EtOH–H O (95:5, v/v), stained with crystal violet solution, and lysed with
2
a solution of 0.1 N HCl in MeOH. The absorbance in control and drug-treated wells was measured in an automated microplate
reader (Bio-Rad 550) at 550 nm.
557